by rss feed | Aug 7, 2026 | News Feeds, Uncategorized
A recent review explores the rapidly expanding field of ferroptosis-based therapy for prostate cancer, presenting ferroptosis as a promising strategy to overcome resistance in advanced and castration-resistant prostate cancer (CRPC).
by rss feed | Jul 10, 2026 | News Feeds, Uncategorized
A systematic review and meta-analysis of seven cohort studies involving more than 40,000 GLP-1 receptor agonist-exposed pregnancies found no statistically significant increase in major congenital malformations or several other adverse pregnancy outcomes. However, the...
by rss feed | Jun 29, 2026 | Uncategorized
Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.
by rss feed | Jun 25, 2026 | News Feeds, Uncategorized
Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck...
by rss feed | Jun 25, 2026 | News Feeds, Uncategorized
Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck...
by rss feed | Jun 15, 2026 | News Feeds, Uncategorized
People with type 2 diabetes who nap longer than 30 minutes every day, regardless of their sleep patterns at night, increase their risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study being presented Monday at ENDO...
